ETFs are becoming a signal of who’s entering the big leagues 👀
We've seen $SOL and $XRP attract institutional attention through the ETF narrative, and I believe the next wave could bring more overlooked networks into the spotlight.
This is where Injective gets interesting.
Canary Capital's proposed Staked INJ ETF signals that traditional finance is beginning to explore INJ as an investable asset, with staking potentially built into the product.
To me, that's a meaningful step toward the same institutional conversation surrounding much larger crypto assets.
Yet I believe Injective remains undervalued relative to its ambitions, infrastructure, and growing institutional relevance.
The market may still be underestimating where $INJ is heading 🔥
#Altcoin Season#
We've seen $SOL and $XRP attract institutional attention through the ETF narrative, and I believe the next wave could bring more overlooked networks into the spotlight.
This is where Injective gets interesting.
Canary Capital's proposed Staked INJ ETF signals that traditional finance is beginning to explore INJ as an investable asset, with staking potentially built into the product.
To me, that's a meaningful step toward the same institutional conversation surrounding much larger crypto assets.
Yet I believe Injective remains undervalued relative to its ambitions, infrastructure, and growing institutional relevance.
The market may still be underestimating where $INJ is heading 🔥
#Altcoin Season#
